Actively Recruiting
Misoprostol Before Caesarean Section
Led by Kafrelsheikh University · Updated on 2025-05-13
160
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
CONDITIONS
Official Title
Misoprostol Before Caesarean Section
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women scheduled for elective caesarean section
- Age less than 35 years
- Gestational age less than 38 weeks
- Gestational age confirmed by certain last menstrual period or reliable early ultrasound
- Singleton pregnancy with no major anomalies
You will not qualify if you...
- Presence of obstetric disorders such as preeclampsia or diabetes
- Fetus with oligohydramnios or intrauterine growth restriction
- Contraindications to misoprostol, including allergy, hemorrhagic disorders, or severe anemia
- History of two or more previous cesarean sections
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kafr El-sheikh University Hospital
Kafr Ash Shaykh, Egypt, Egypt
Actively Recruiting
Research Team
M
Merna Ashraf Ahmed farid, M.B.B.C.H
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here